ELOVANOID Trademark

Trademark Overview


On Thursday, February 8, 2018, a trademark application was filed for ELOVANOID with the United States Patent and Trademark Office. The USPTO has given the ELOVANOID trademark a serial number of 87790778. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 29, 2021. This trademark is owned by Neuresto Therapeutics, LLC. The ELOVANOID trademark is filed in the Cosmetics & Cleaning Products and Pharmaceutical Products categories with the following description:

Age retardant gel; Age retardant lotion; Age spot reducing creams; Anti-aging cream; Anti-aging moisturizer; Anti-aging moisturizers used as cosmetics; Anti-aging toner; Anti-wrinkle cream; Cosmetic body care preparations, namely, creams, lotions, gels, toners, serums, cleaners and peels aimed at treating or preventing aging or treating, preventing or reducing the appearance of aging of skin; Non-medicated anti-aging serum; Non-medicated skin care preparations, namely, creams, lotions, gels, toners, serums, cleaners and peels aimed at treating or preventing aging or treating, preventing or reducing the appearance of aging of skin

Chemical preparations for pharmaceutical or medical purposes, namely, for treating or preventing retinal degeneration diseases, vision loss, damage to neural cells, spinal cord injury, traumatic brain injury, concussion(s), Alzheimer; Glaucoma agents; Medicaments for treating or preventing retinal degeneration diseases, vision loss, damage to neural cells, spinal cord injury, traumatic brain injury, concussion(s), Alzheimer; Medicated skin or face moisturizers; Medicinal preparations for treating or preventing retinal degeneration diseases, vision loss, damage to neural cells, spinal cord injury, traumatic brain injury, concussion(s), Alzheimer; Ocular pharmaceuticals; Pharmaceutical preparations for the treatment and prevention of retinal degeneration diseases, vision loss, damage to neural cells, spinal cord injury, traumatic brain injury, concussion(s), Alzheimer; Pharmaceutical products for ophthalmological use; Pharmaceutical preparations, namely, a topical preparation for the tre...
elovanoid

General Information


Serial Number87790778
Word MarkELOVANOID
Filing DateThursday, February 8, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 29, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 26, 2018

Trademark Statements


Goods and ServicesAge retardant gel; Age retardant lotion; Age spot reducing creams; Anti-aging cream; Anti-aging moisturizer; Anti-aging moisturizers used as cosmetics; Anti-aging toner; Anti-wrinkle cream; Cosmetic body care preparations, namely, creams, lotions, gels, toners, serums, cleaners and peels aimed at treating or preventing aging or treating, preventing or reducing the appearance of aging of skin; Non-medicated anti-aging serum; Non-medicated skin care preparations, namely, creams, lotions, gels, toners, serums, cleaners and peels aimed at treating or preventing aging or treating, preventing or reducing the appearance of aging of skin
Goods and ServicesChemical preparations for pharmaceutical or medical purposes, namely, for treating or preventing retinal degeneration diseases, vision loss, damage to neural cells, spinal cord injury, traumatic brain injury, concussion(s), Alzheimer; Glaucoma agents; Medicaments for treating or preventing retinal degeneration diseases, vision loss, damage to neural cells, spinal cord injury, traumatic brain injury, concussion(s), Alzheimer; Medicated skin or face moisturizers; Medicinal preparations for treating or preventing retinal degeneration diseases, vision loss, damage to neural cells, spinal cord injury, traumatic brain injury, concussion(s), Alzheimer; Ocular pharmaceuticals; Pharmaceutical preparations for the treatment and prevention of retinal degeneration diseases, vision loss, damage to neural cells, spinal cord injury, traumatic brain injury, concussion(s), Alzheimer; Pharmaceutical products for ophthalmological use; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations for ocular or intraocular surgery

Classification Information


International Class003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.
US Class Codes001, 004, 006, 050, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 16, 2018
Primary Code003
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 16, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeuresto Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew Orleans, LA 70163

Party NameNeuresto Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew Orleans, LA 70163

Trademark Events


Event DateEvent Description
Monday, March 29, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 29, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 21, 2020EXTENSION 4 GRANTED
Friday, August 21, 2020EXTENSION 4 FILED
Friday, August 21, 2020TEAS EXTENSION RECEIVED
Wednesday, February 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 3, 2020EXTENSION 3 GRANTED
Monday, February 3, 2020EXTENSION 3 FILED
Monday, February 3, 2020TEAS EXTENSION RECEIVED
Friday, July 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 10, 2019EXTENSION 2 GRANTED
Wednesday, July 10, 2019EXTENSION 2 FILED
Wednesday, July 10, 2019TEAS EXTENSION RECEIVED
Saturday, February 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 31, 2019EXTENSION 1 GRANTED
Thursday, January 31, 2019EXTENSION 1 FILED
Thursday, January 31, 2019TEAS EXTENSION RECEIVED
Tuesday, August 21, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 26, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 26, 2018PUBLISHED FOR OPPOSITION
Wednesday, June 6, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 23, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 23, 2018ASSIGNED TO EXAMINER
Friday, February 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 12, 2018NEW APPLICATION ENTERED IN TRAM